OncoZenge CMO to present BupiZenge Phase III at Pain Therapeutics Summit
OncoZenge AB said its CMO Marie-Louise Fjällskog will present the Phase III program for BupiZenge™ at the 20th Annual Pain Therapeutics Summit in the San Francisco Bay Area on September 28–29.